MetaCap

Aurora Cannabis Stock Forecast

NASDAQ: ACBHealth Care Medicinal Chemicals and Botanical Products USD

4.43-0.03 (-0.67%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

ACB analyst consensus

Consensus (5 analysts)

buy

  • Strong buy 0
  • Buy 2
  • Hold 3
  • Sell 0
  • Strong sell 0

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

What analysts say

According to 5 Wall Street analysts covering Aurora Cannabis (2026-10-08), 2 rate the stock a buy or strong buy, 3 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ACB.

Summary generated from market data by MetaCap's automated system. Methodology

Rating distribution

Aurora Cannabis analyst rating distribution
RatingAnalystsShare
Strong buy00%
Buy240%
Hold360%
Sell00%
Strong sell00%

Ratings as of 2026-10-08.

How analysts view Aurora Cannabis's peers

Peer analyst targets
CompanyConsensusPriceAvg. targetImplied move
USNAnone14.63$25.00+70.94%
SNDLnone1.22$3.46+183.61%
OBIOstrong_buy5.73$12.43+116.93%
NAGEstrong_buy2.66$12.08+354.14%
CGCnone0.8468$1.19+40.53%
MDWDstrong_buy12.42$30.67+146.94%

Related